Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular Cancer

Carsten Bokemeyer, A. Gerl, P. Schöffski, +6

Journal of Clinical Oncology

Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group

P. Schöffski, S. Riggert, P. Fumoleau, +10

Annals of Oncology

Surgical OncologySolid TumorsMedicinePharmacologyPharmacotherapy +7

Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study

P. Schöffski, Benjamin Besse, Thomas Gauler, +7

Annals of Oncology

Non-small-cell Lung CancerBiweekly I.vMedicineCancer ManagementPharmacology +7

Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.

Debbie Debaere, Vincent Vander Poorten, Sandra Nuyts, +4

PubMed

A phase I pharmacokinetic (PK) and molecular pharmacodynamic (PD) study of the combination of two anti-EGFR therapies, the monoclonal antibody (MAb) cetuximab (C) and the tyrosine kinase inhibitor (TKI) gefitinib (G), in patients (pts) with advanced colorectal (CRC), head and neck (HNC) and non-small cell lung cancer (NSCLC)

José Baselga, P. Schöffski, Federico Rojo, +6

Journal of Clinical Oncology

Oral Daily GPathologyPharmacotherapySuperior PdTumor Biology +14

European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy

Nathan Touati, P. Schöffski, Saskia Litière, +11

Clinical Oncology

European OrganisationSurgical OncologyMedicineCancer ManagementPathology +6

AEE788, a novel multitargeted inhibitor of ErbB and VEGF receptor family tyrosine kinases: Preliminary phase 1 results

Elisa Martina Martinelli, Chris H. Takimoto, A.T. van Oosterom, +7

Journal of Clinical Oncology

Preliminary Phase 1PharmacotherapyTumor BiologyPre-clinical PharmacologySignaling Pathway +21

Phase I accelerated dose-escalation, pharmacokinetic (PK) and pharmacodynamic study of PF-03814735, an oral aurora kinase inhibitor, in patients with advanced solid tumors: Preliminary results

Suzanne F. Jones, Howard A. Burris, Herlinde Dumez, +7

Journal of Clinical Oncology

Aurora APathologyPharmacotherapyAurora BAdvanced Solid Tumors +16

Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial.

Hans‐Joachim Schmoll, C H Köhne-Wömpner, W. Hiddemann, +6

PubMed

A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials

A. Doussau, Rodolphe Thiébaut, Birgit Geoerger, +8

Annals of Oncology

OncologyPreclinical Drug EvaluationClinical Trial AnalysisPharmacologyDose-finding Trials +8